IL89790A - Sequences of nucleic acids encoding and cells producing CR1 protein and methods for its production and purification - Google Patents

Sequences of nucleic acids encoding and cells producing CR1 protein and methods for its production and purification

Info

Publication number
IL89790A
IL89790A IL8979089A IL8979089A IL89790A IL 89790 A IL89790 A IL 89790A IL 8979089 A IL8979089 A IL 8979089A IL 8979089 A IL8979089 A IL 8979089A IL 89790 A IL89790 A IL 89790A
Authority
IL
Israel
Prior art keywords
crl
cell
nucleic acid
recombinant
sequence
Prior art date
Application number
IL8979089A
Other languages
English (en)
Hebrew (he)
Other versions
IL89790A0 (en
Original Assignee
Johns Hopking University
Brigham & Womens Hospital
Avant Immunotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johns Hopking University, Brigham & Womens Hospital, Avant Immunotherapeutics Inc filed Critical Johns Hopking University
Publication of IL89790A0 publication Critical patent/IL89790A0/xx
Publication of IL89790A publication Critical patent/IL89790A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3153—Streptokinase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Joining Of Building Structures In Genera (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL8979089A 1988-04-01 1989-03-29 Sequences of nucleic acids encoding and cells producing CR1 protein and methods for its production and purification IL89790A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17653288A 1988-04-01 1988-04-01
US41274589A 1989-09-26 1989-09-26

Publications (2)

Publication Number Publication Date
IL89790A0 IL89790A0 (en) 1989-09-28
IL89790A true IL89790A (en) 2002-05-23

Family

ID=26872337

Family Applications (1)

Application Number Title Priority Date Filing Date
IL8979089A IL89790A (en) 1988-04-01 1989-03-29 Sequences of nucleic acids encoding and cells producing CR1 protein and methods for its production and purification

Country Status (14)

Country Link
EP (1) EP0411031B1 (no)
JP (1) JP3484189B2 (no)
CN (2) CN1092712C (no)
AT (1) ATE240973T1 (no)
CA (2) CA1340866C (no)
DE (1) DE68929466T2 (no)
DK (1) DK175699B1 (no)
ES (1) ES2014593A6 (no)
FI (2) FI106316B (no)
IL (1) IL89790A (no)
NO (1) NO315944B1 (no)
SG (1) SG52789A1 (no)
WO (1) WO1989009220A1 (no)
ZA (2) ZA892397B (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5426029A (en) * 1986-03-31 1995-06-20 T Cell Diagnostics, Inc. Therapeutic and diagnostic methods using leukocyte surface antigens
US5256642A (en) * 1988-04-01 1993-10-26 The Johns Hopkins University Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof
MY107433A (en) * 1989-10-12 1995-12-30 Imutran Ltd Modiefied biological material.
US6482404B1 (en) 1989-10-12 2002-11-19 David James White Transplantation of tissue comprising a DNA sequence encoding a homologous complement restriction factor
US6552170B1 (en) 1990-04-06 2003-04-22 Amgen Inc. PEGylation reagents and compounds formed therewith
US6458360B1 (en) * 1990-04-25 2002-10-01 The Johns Hopkins University Soluble complement regulatory molecules
DK0574402T3 (da) * 1990-11-26 1998-05-18 Chiron Corp Ekspression af PACE i værtsceller og fremgangsmåder til anvendelse deraf
EP0560929A1 (en) * 1990-12-06 1993-09-22 T Cell Sciences, Inc. Synergistic compositions of soluble complement receptors and compounds that inhibit complement and/or suppress immune activity
EP0512733A2 (en) 1991-05-03 1992-11-11 Washington University Modified complement system regulator
WO1994000571A1 (en) * 1992-06-24 1994-01-06 Smithkline Beecham Plc Soluble cr1 derivatives
US5456909A (en) * 1992-08-07 1995-10-10 T Cell Sciences, Inc. Glycoform fractions of recombinant soluble complement receptor 1 (sCR1) having extended half-lives in vivo
AU685433B2 (en) * 1993-02-12 1998-01-22 Regents Of The University Of Minnesota Pulmonary administration of sCR1 and other complement inhibitory proteins
US5951976A (en) 1996-03-28 1999-09-14 Whitenead Institute For Biomedical Research Opsonin-enhanced cells, and methods of modulating an immune response to an antigen
TW555765B (en) 1996-07-09 2003-10-01 Amgen Inc Low molecular weight soluble tumor necrosis factor type-I and type-II proteins
GB9706950D0 (en) * 1997-04-05 1997-05-21 Chernajovsky Yuti Immune modulation by polypeptides related to CR1
WO2000005413A1 (en) * 1998-07-24 2000-02-03 Uab Research Foundation Genetic polymorphism in a complement receptor
US6664052B1 (en) 1998-07-24 2003-12-16 The Uab Research Foundation Genetic polymorphism in a complement receptor
GB9905503D0 (en) 1999-03-10 1999-05-05 Adprotech Plc Novel compound formulations and methods of delivery
EP1738763A1 (en) 2005-06-30 2007-01-03 AVANT Immunotherapeutics, Inc. Use of complement inhibitory proteins to treat spinal cord injury
PL3028716T3 (pl) 2006-10-10 2021-03-08 Regenesance B.V. Hamowanie układu dopełniacza służące do lepszej regeneracji nerwów
JP5795961B2 (ja) 2008-10-21 2015-10-14 ザ ジェネラル ホスピタル コーポレイション 細胞移植
US10184110B2 (en) 2010-08-06 2019-01-22 The General Hospital Corporation System and apparatus for cell treatment
CN103237557A (zh) 2010-09-15 2013-08-07 赛尔戴克斯治疗公司 用可溶性I型补体受体(sCR1)治疗慢性肾病
CA2815237C (en) 2010-10-27 2018-10-09 Celldex Therapeutics, Inc. Method of improving transplant function using soluble complement receptor type i (scr1)
ES2564290T3 (es) 2010-11-02 2016-03-21 Kypha, Inc. Inmunoensayo de flujo lateral para la activación de complemento y métodos de uso para evaluación del sitio de atención de trastornos asociados a complemento
CN102702339B (zh) * 2011-05-24 2013-10-30 华南师范大学 斜带石斑鱼补体c3基因、载体、重组菌株和蛋白及其应用
CN110078831A (zh) * 2011-12-01 2019-08-02 圆祥生命科技股份有限公司 补体和vegf途径的蛋白质抑制剂及其使用方法
US10531655B2 (en) 2011-12-02 2020-01-14 The Regents Of The University Of California Reperfusion protection solution and uses thereof
CN104293836A (zh) * 2014-06-24 2015-01-21 长沙赢润生物技术有限公司 一种免疫复合物吸附细胞的制作方法
GB201800620D0 (en) 2018-01-15 2018-02-28 Univ Manchester C3b Binding Polypeptide
EP3760645A1 (en) * 2019-07-02 2021-01-06 imusyn GmbH & Co. KG Analysis for blood group antigen dacy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60192948A (ja) * 1984-03-14 1985-10-01 Fuji Photo Film Co Ltd 湿し水不要ネガ型感光性平版印刷版および製版方法
US4672044A (en) * 1984-08-24 1987-06-09 Scripps Clinic & Research Foundation Murine monoclonal antibody combining site to human C3b receptor (CR1)

Also Published As

Publication number Publication date
FI115528B (fi) 2005-05-31
FI106316B (fi) 2001-01-15
JPH04501502A (ja) 1992-03-19
AU647371B2 (en) 1994-03-24
DE68929466T2 (de) 2004-04-01
CA1340866C (en) 1999-12-28
NO315944B1 (no) 2003-11-17
WO1989009220A1 (en) 1989-10-05
ZA907693B (en) 1992-05-27
FI20002515A (fi) 2000-11-16
IL89790A0 (en) 1989-09-28
DK175699B1 (da) 2005-01-24
EP0411031A4 (en) 1992-02-05
CA1341443C (en) 2003-10-07
CN1092712C (zh) 2002-10-16
DE68929466D1 (de) 2003-06-26
CN1036987A (zh) 1989-11-08
EP0411031A1 (en) 1991-02-06
CN1053265A (zh) 1991-07-24
NO20000827D0 (no) 2000-02-18
DK234890A (da) 1990-11-30
EP0411031B1 (en) 2003-05-21
ZA892397B (en) 1989-11-29
NO20000827L (no) 1990-11-09
SG52789A1 (en) 1998-09-28
ATE240973T1 (de) 2003-06-15
FI904842A0 (fi) 1990-10-01
ES2014593A6 (es) 1990-07-16
CN1053924C (zh) 2000-06-28
JP3484189B2 (ja) 2004-01-06
DK234890D0 (da) 1990-09-28
AU3539489A (en) 1989-10-16

Similar Documents

Publication Publication Date Title
US6316604B1 (en) Human C3b/C4b receptor (CR1)
US5981481A (en) Human C3b/C4b receptor (CR1)
EP0411031B1 (en) THE HUMAN C3b/C4b RECEPTOR (CR1)
AU656312B2 (en) The human C3b/C4b receptor (CR1)
JP3860605B2 (ja) 補体活性化をブロックするキメラタンパク質
JP2869920B2 (ja) 組織因子タンパク質を製造するためのデオキシリボ核酸
AU7745891A (en) Gpib(alpha) fragments and recombinant dna expression vectors
US5208144A (en) Method for detection of human dna containing the gene encoding low density lipoprotein receptor
EP0913470A2 (en) The human C3b/C4b receptor (CR1)
AU647371C (en) The human C3b/C4b receptor (CR1)
US20020110864A1 (en) Polypeptide and DNAs encoding it
NO310078B1 (no) Nukleinsyresekvens kodende for CR1-protein, ekspresjonsvektor samt rekombinant celle omfattende nevnte sekvens og en fremgangsmåte for å fremstille nevnte protein
EP0358977A1 (en) Cloned nephritis antigen
US6750323B1 (en) Platelet activation protein

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed